Mar 9, 2023 Cellectar Reports Financial Results for Year Ended 2022 and Provides a Corporate Update Learn More
Feb 28, 2023 Cellectar Biosciences Reports Complete Response in a Relapsed/Refractory CNS Lymphoma Patient Learn More
Feb 15, 2023 Cellectar Biosciences Hires Dr. Andrei Shustov as New Senior Vice President, Medical Learn More